- Home
- IFBD vs CNSP Comparison
IFBD vs CNSP Comparison
Compare IFBD & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IFBD | CNSP |
|---|---|---|
| Founded | 2001 | 2017 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5M | 7.3M |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | IFBD | CNSP |
|---|---|---|
| Price | $0.92 | $3.99 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | ★ 147.9K | 15.5K |
| Earning Date | 05-01-2023 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 8.03 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.66 | $0.80 |
| 52 Week High | $2.18 | $10.59 |
Technical Indicators
Market Signals| Indicator | IFBD | CNSP |
|---|---|---|
| Relative Strength Index (RSI) | 48.72 | 41.60 |
| Support Level | $0.88 | $2.01 |
| Resistance Level | $1.13 | $5.61 |
| Average True Range (ATR) | 0.22 | 0.29 |
| MACD | -0.01 | -0.10 |
| Stochastic Oscillator | 9.13 | 22.80 |
Price Performance
Historical ComparisonAbout IFBD Infobird Co. Ltd
Infobird Co Ltd is a software-as-a-service (SaaS) provider of AI-powered customer engagement solutions in China. The Company provides standard and customized customer relationship management cloud-based services, including SaaS and business process outsourcing (BPO) services. It generates revenue from the development and sale of software licenses for customized software, as well as from business integration solution services and digital advertising and marketing campaign services. Digital advertising revenue is generated from developing and executing advertising plans based on customer needs, and the Company generally provides limited warranties for work performed under its business integration solution contracts. The Company generates maximum revenue from its operations in Mainland China.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.